LEADER 05603nam 2200697Ia 450 001 9910144110203321 005 20170809153208.0 010 $a1-281-84288-5 010 $a9786611842888 010 $a3-527-61567-9 010 $a3-527-61566-0 035 $a(CKB)1000000000552489 035 $a(EBL)481384 035 $a(OCoLC)289098579 035 $a(SSID)ssj0000097642 035 $a(PQKBManifestationID)11130869 035 $a(PQKBTitleCode)TC0000097642 035 $a(PQKBWorkID)10119879 035 $a(PQKB)11699598 035 $a(MiAaPQ)EBC481384 035 $a(EXLCZ)991000000000552489 100 $a19941020d1995 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAdvanced computer-assisted techniques in drug discovery$b[electronic resource] /$fedited by Han van de Waterbeemd 210 $aWeinheim ;$aNew York $cVCH$dc1995 215 $a1 online resource (367 p.) 225 1 $aMethods and principles in medicinal chemistry ;$vv. 3 300 $aDescription based upon print version of record. 311 $a3-527-29248-9 320 $aIncludes bibliographical references and index. 327 $aAdvanced Computer- Assisted Techniques in Drug Discovery; Preface; A Personal Foreword; Contents; 1 Introduction; 1.1 3D QSAR; 1.2 Databases; 1.3 Progress in Multivariate Data Analysis; 1.4 Scope of this Book; References; 2 3D QSAR: The Integration of QSAR with Molecular Modeling; 2.1 Chemometrics and Molecular Modeling; 2.1.1 Introduction; 2.1.2 QSAR Methodology using Molecular Modeling and Chemometrics; 2.1.2.1 Search for the Geometric Pharmacophore; 2.1.2.2 Quantitative Correlation between Molecular Properties and Activity; 2.1.2.3 Computer Programs; 2.1.3 Illustrative Examples 327 $a2.1.3.1 Amnesia-Reversal Compounds2.1.3.2 Non-Peptide Angiotensin II Receptor Antagonists; 2.1.3.3 HMG-CoA Reductase Inhibitors; 2.1.3.4 Antagonists at the 5-HT3 Receptor; 2.1.3.5 Polychlorinated Dibenzo-p-dioxins; 2.1.4 Conclusions; References; 2.2 3D QSAR Methods; 2.2.1 Introduction; 2.2.2 3D QSAR of a Series of Calcium Channel Agonists; 2.2.2.1 Molecular Alignment; 2.2.2.2 Charges; 2.2.2.3 Generating 3D Fields; 2.2.2.4 Compilation of GRID Maps; 2.2.2.5 Inclusion of Macroscopic Descriptors with 3D Field Data; 2.2.3 Statistical Analysis; 2.2.3.1 Results of the Analysis 327 $a2.2.3.2 Testing the Model2.2.4 Conclusions; References; 2.3 GOLPE Philosophy and Applications in 3D QSAR; 2.3.1 Introduction; 2.3.1.1 3D Molecular Descriptors and Chemometric Tools; 2.3.1.2 Unfolding Three-way Matrices; 2.3.2 The GOLPE Philosophy; 2.3.2.1 Variable Selection; 2.3.3 Applications; 2.3.3.1 PCA on the Target Matrix; 2.3.3.2 PCA on the Probe Matrix; 2.3.3.3 PLS Analysis on the Target Matrix; 2.3.3.4 PLS on Target Matrix as a Strategy to Ascertain the Active Conformation; 2.3.3.5 GOLPE with Different 3D Descriptors; 2.3.4 Conclusions and Perspectives; References 327 $a3 Rational Use of Chemical and Sequence Databases3.1 Molecular Similarity Analysis: Applications in Drug Discovery; 3.1.1 Introduction; 3.1.2 Similarity-Based Compound Selection; 3.1.2.1 Similarity Measures and Neighborhoods; 3.1.2.2 Application of 2D and 3D Similarity Measures; 3.1.2.3 Application of Dissimilarity-Based Compound Selection for Broad Screening; 3.1.3 Structure-Activity Maps (SAMs); 3.1.3.1 A Visual Analogy; 3.1.3.2 Representing Inter-Structure Distances; 3.1.3.3 Structure Maps; 3.1.3.4 Coloring a Structure Map; 3.1.4 Field-Based Similarity Methods 327 $a3.1.4.1 Field-Based Similarity Measures3.1.4.2 Field-Based Molecular Superpositions; 3.1.4.3 An Example of Field-Based Fitting: Morphine and Clonidine; 3.1.5 Conclusions; References; 3.2 Clustering of Chemical Structure Databases for Compound Selection; 3.2.1 Introduction; 3.2.2 Review of Clustering Methods; 3.2.2.1 Hierarchical Clustering Methods; 3.2.2.2 Non-Hierarchical Clustering Methods; 3.2.3 Choice of Clustering Method; 3.2.3.1 Computational Requirements; 3.2.3.2 Cluster Shapes; 3.2.3.3 Comparative Studies 327 $a3.2.4 Examples of the Selection of Compounds from Databases by Clustering Techniques 330 $aThe use of powerful computers has revolutionized molecular design and drug discovery. Thoroughly researched and well-structured, this comprehensive handbook covers highly effective and efficient techniques in 3D-QSAR and advanced statistical analysis. The emphasis is on showing users how to apply these methods and avoid costly and time-consuming methodical errors.Topics covered include* combination of statistical methods and molecular modeling tools* rational use of databases* advanced statistical techniques* neural networks and expert systems in molecular design
801 0$aIT$bUNINA$gREICAT$2UNIMARC 901 $aBK 912 $a9910844901403321 952 $aVI Z 314$b2024/205$fFGBC 959 $aFGBC 996 $aCommentario al Codice dei contratti pubblici 2023$94149534 997 $aUNINA LEADER 04112nam 22006255 450 001 9910380744903321 005 20250609110107.0 010 $a3-030-39240-6 024 7 $a10.1007/978-3-030-39240-6 035 $a(CKB)4100000010480331 035 $a(MiAaPQ)EBC6126754 035 $a(DE-He213)978-3-030-39240-6 035 $a(MiAaPQ)EBC6126444 035 $a(EXLCZ)994100000010480331 100 $a20200227d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 14$aThe Balanced Development Index for Europe?s OECD countries, 1999?2017 /$fby Andrzej K. Ko?mi?ski, Adam Noga, Katarzyna Piotrowska, Krzysztof Zagórski 205 $a1st ed. 2020. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2020. 215 $a1 online resource (123 pages) 225 1 $aSpringerBriefs in Economics,$x2191-5504 311 08$a3-030-39239-2 327 $aChapter 1: Introduction -- Chapter 2: GDP Shortcomings and a Brief History of Creating General Measures of Socio-Economic Development -- Chapter 3: Conceptual and Theoretical Basis of Balanced Development Index (BDI) -- Chapter 4: To Weight or Not to Weight? -- Chapter 5: Four Domains of Socio-Economic Development and their Indicators as BDI Components -- Chapter 6: International Differences in the Level and Pace of Socio-Economic Development -- Chapter 7: Chainges in BDI, its Four Components and GDP -- Chapter 8: BDI, Other Composite Measures of Socio-Economic Conditions and Happiness -- Chapter 9: Case Study: Poland -- Chapter 10: Emotional and Rational Countries -- Chapter 11: Development and Socio-Economic Balance -- Chapter 12: Conclusions. 330 $aThis book presents the Balanced Development Index (BDI), measuring socioeconomic development in twenty-two European OECD member countries in a period 1999-2017. Compared to other composite measures of development, BDI looks beyond traditional development indicators, such as GDP, to create an index which gives equal weight to social, economic, objective, and subjective aspects of development. The BDI aggregates forty-two detailed indicators into four composite middle-level indexes: external economic (characterizing functioning of national economies in their international surroundings), internal economic (characterizing various aspects of domestic economic conditions), social expectations (public hopes and fears concerning economic, political and social conditions), and current social condition (including both objective and subjective social indicators)?which are, in turn, aggregated into the general BDI index. 410 0$aSpringerBriefs in Economics,$x2191-5504 606 $aDevelopment economics 606 $aEurope?Economic conditions 606 $aEconomic policy 606 $aEconomics 606 $aDevelopment Economics$3https://scigraph.springernature.com/ontologies/product-market-codes/W42000 606 $aEuropean Economics$3https://scigraph.springernature.com/ontologies/product-market-codes/W45030 606 $aPolitical Economy/Economic Systems$3https://scigraph.springernature.com/ontologies/product-market-codes/W46000 615 0$aDevelopment economics. 615 0$aEurope?Economic conditions. 615 0$aEconomic policy. 615 0$aEconomics. 615 14$aDevelopment Economics. 615 24$aEuropean Economics. 615 24$aPolitical Economy/Economic Systems. 676 $a338.94 700 $aKoz?min?ski$b Andrzej K.$4aut$4http://id.loc.gov/vocabulary/relators/aut$0676621 702 $aNoga$b Adam$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aPiotrowska$b Katarzyna$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aZago?rski$b Krzysztof$4aut$4http://id.loc.gov/vocabulary/relators/aut 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910380744903321 996 $aThe Balanced Development Index for Europe?s OECD Countries, 1999?2017$92085017 997 $aUNINA LEADER 03906oas 2201525 a 450 001 9910131790803321 005 20251105213014.0 011 $a1572-0241 035 $a(DE-599)ZDB2003227-4 035 $a(DE-599)2003227-4 035 $a(OCoLC)43064774 035 $a(CONSER) 2004700000 035 $a(CKB)954925377892 035 $a(EXLCZ)99954925377892 100 $a19991220a19549999 sy 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 04$aThe American journal of gastroenterology 210 $a[Amsterdam] $a[New York] $cElsevier 210 2 $a[Malden, MA] $cBlackwell 210 2 $a[London] $cNature Pub. Group 210 3 $aNrew York $cNature Pub. Group 215 $a1 online resource 300 $aRefereed/Peer-reviewed 311 08$a0002-9270 517 1 $aAJG 606 $aStomach$xDiseases$vPeriodicals 606 $aIntestines$xDiseases$vPeriodicals 606 $aGastrointestinal system$xDiseases 606 $aDigestive organs$vPeriodicals 606 $aGastroenterology 606 $aGastrointestinal Diseases 606 $aIntestins$xMaladies$vPe?riodiques 606 $aAppareil digestif$vPe?riodiques 606 $aEstomac$xMaladies$vPe?riodiques 606 $aTractus gastro-intestinal$xMaladies 606 $aGastrointestinal system$xDiseases$2fast$3(OCoLC)fst00938871 606 $aDigestive organs$2fast$3(OCoLC)fst00893585 606 $aIntestines$xDiseases$2fast$3(OCoLC)fst00977675 606 $aStomach$xDiseases$2fast$3(OCoLC)fst01133774 606 $aGastro-enterologie$2gtt 608 $aPeriodical. 608 $aperiodicals.$2aat 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aPe?riodiques.$2rvmgf 615 0$aStomach$xDiseases 615 0$aIntestines$xDiseases 615 0$aGastrointestinal system$xDiseases. 615 0$aDigestive organs 615 2$aGastroenterology. 615 2$aGastrointestinal Diseases. 615 6$aIntestins$xMaladies 615 6$aAppareil digestif 615 6$aEstomac$xMaladies 615 6$aTractus gastro-intestinal$xMaladies. 615 7$aGastrointestinal system$xDiseases. 615 7$aDigestive organs. 615 7$aIntestines$xDiseases. 615 7$aStomach$xDiseases. 615 17$aGastro-enterologie. 676 $a616.33 712 02$aNational Gastroenterological Association (U.S.) 712 02$aAmerican College of Gastroenterology 801 0$bPIT 801 1$bPIT 801 2$bOCL 801 2$bOCLCQ 801 2$bPIT 801 2$bOCLCQ 801 2$bOCL 801 2$bCLU 801 2$bOCLCQ 801 2$bTEF 801 2$bLGG 801 2$bCSU 801 2$bAU@ 801 2$bFFQ 801 2$bCCO 801 2$bOCLCQ 801 2$bBUF 801 2$bOCLCQ 801 2$bDLC 801 2$bSERSO 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCQ 801 2$bSCB 801 2$bOCLCO 801 2$bOCLCA 801 2$bZ5A 801 2$bOCLCO 801 2$bOCLCA 801 2$bEZC 801 2$bOCLCO 801 2$bWYU 801 2$bOCLCO 801 2$bUKMGB 801 2$bOCLCO 801 2$bTKN 801 2$bVT2 801 2$bOCLCQ 801 2$bLEAUB 801 2$bOCLCO 801 2$bUPM 801 2$bOCLCO 801 2$bOCLCA 801 2$bW2U 801 2$bOCLCE 801 2$bDKU 801 2$bSFB 801 2$bS2H 801 2$bWURST 801 2$bOCLCO 801 2$bUAB 801 2$bOCLCQ 801 2$bOCLCO 801 2$bQGK 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCL 801 2$bOCLCL 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910131790803321 996 $aAmerican journal of gastroenterology$9802042 997 $aUNINA LEADER 02975nam 2201009zu 450 001 9910155288903321 005 20210803233159.0 010 $a9783318018202 010 $a3318018201 035 $a(CKB)3780000000101629 035 $a(SSID)ssj0000578673 035 $a(PQKBManifestationID)12216704 035 $a(PQKBTitleCode)TC0000578673 035 $a(PQKBWorkID)10588224 035 $a(PQKB)11181954 035 $a(OCoLC)849647624 035 $a(SZ-BaSKA)222150 035 $a(MiAaPQ)EBC31866115 035 $a(Au-PeEL)EBL31866115 035 $a(Perlego)825492 035 $a(EXLCZ)993780000000101629 100 $a20160829d1991 uy 101 0 $aeng 135 $aurunu||||| 181 $ctxt 182 $cc 183 $acr 200 00$aIntegrins and ICMA-1 in immune responses 205 $a1st ed. 210 31$a[Place of publication not identified]$cKarger$d1991 215 $a1 online resource (VIII + 168 pages) : $c 21 figures, 11 tables 225 1 $aIssn Series 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9783805554299 311 08$a380555429X 327 $aCIA199105000I.PDF.pdf -- CIA1991050001 -- CIA1991050013 -- CIA1991050034 -- CIA1991050055 -- CIA1991050075 -- CIA1991050089 -- CIA1991050098 -- CIA1991050116 -- CIA1991050135 -- CIA1991050143 -- CIA1991050165. 410 0$aIssn Series 606 $aImmune System 606 $aDisease 606 $aAntigens, Surface 606 $aBlood Cells 606 $aMembrane Glycoproteins 606 $aReceptors, Immunologic 606 $aGlycoproteins 606 $aAntigens 606 $aBlood 606 $aMembrane Proteins 606 $aHemic and Immune Systems 606 $aCells 606 $aReceptors, Cell Surface 606 $aAnatomy 606 $aProteins 606 $aBiological Factors 606 $aAmino Acids, Peptides, and Proteins 606 $aChemicals and Drugs 606 $aLeukocytes 606 $aCell Adhesion Molecules 606 $aIntegrins 606 $aNeoplasms 615 2$aImmune System. 615 2$aDisease. 615 2$aAntigens, Surface. 615 2$aBlood Cells. 615 2$aMembrane Glycoproteins. 615 2$aReceptors, Immunologic. 615 2$aGlycoproteins. 615 2$aAntigens. 615 2$aBlood. 615 2$aMembrane Proteins. 615 2$aHemic and Immune Systems. 615 2$aCells. 615 2$aReceptors, Cell Surface. 615 2$aAnatomy. 615 2$aProteins. 615 2$aBiological Factors. 615 2$aAmino Acids, Peptides, and Proteins. 615 2$aChemicals and Drugs 615 2$aLeukocytes. 615 2$aCell Adhesion Molecules. 615 2$aIntegrins. 615 2$aNeoplasms. 702 $aHogg$b Nancy 801 0$bPQKB 906 $aBOOK 912 $a9910155288903321 996 $aIntegrins and ICMA-1 in immune responses$92788774 997 $aUNINA